<?xml version="1.0" encoding="UTF-8"?>
<ref id="zoi201035r29">
 <label>29</label>
 <mixed-citation publication-type="web">Eliminating surgery after systemic therapy in treating patients with HER2 positive or triple negative breast cancer. ClinicalTrials.gov identifier:NCT02945579. Updated July 24, 
  <year>2019</year> Accessed October 20, 2020. 
  <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02945579" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov/ct2/show/NCT02945579</ext-link>
 </mixed-citation>
</ref>
